Organigram Global (OGI) Cash & Equivalents (2023 - 2025)

Organigram Global (OGI) has disclosed Cash & Equivalents for 3 consecutive years, with $60.7 million as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents fell 37.51% to $60.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $60.7 million through Sep 2025, down 37.51% year-over-year, with the annual reading at $59.8 million for FY2025, 38.65% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $60.7 million at Organigram Global, down from $97.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $97.2 million in Q3 2024, with the low at $38.6 million in Q3 2023.
  • Average Cash & Equivalents over 3 years is $65.5 million, with a median of $60.7 million recorded in 2025.
  • The sharpest move saw Cash & Equivalents skyrocketed 151.78% in 2024, then tumbled 37.51% in 2025.
  • Over 3 years, Cash & Equivalents stood at $38.6 million in 2023, then skyrocketed by 151.78% to $97.2 million in 2024, then crashed by 37.51% to $60.7 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $60.7 million, $97.2 million, and $38.6 million for Q3 2025, Q3 2024, and Q3 2023 respectively.